Hims & Hers Health, Inc. HIMS
29.42
0.14
0.48%
as of 25 Sep
- Market cap
- $6.9B
- P/E
- 0.0×
Follow HIMS
Growth Flags
show if company had growth for consecutive years,
Insider Buys
alert about insiders buying in the last 12 month
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
|
+8 more TTM periods Free account |
26.21% | 25.23% | (2.66%) | (32.03%) | |
| 9.44% | 8.97% | (0.84%) | (5.16%) | ||
ROIC |
7.79% | 7.05% | (2.86%) | (11.38%) | |
Return on Tangible Assets |
20.21% | 19.01% | (1.74%) | (53.48%) | |
Average Days of Receivables |
0.00 | 5.00 | 23.05 | 53.13 | |
Free Cash Flow per Share |
0.59 | 0.33 | 0.35 | 0.36 | |
Free Cash Flow |
133.90 | 73.96 | 79.71 | 83.03 | |
Capital Expenditures |
(191.18) | (226.04) | (200.56) | (180.42) | |
Piotroski F-Score |
3.00 | 4.00 | 3.00 | 3.00 | |
| Other line items | |||||
Cash ROIC |
14.90% | 14.35% | 12.91% | 10.41% | |
Accounts Receivable Turnover |
0.00 | 132.71 | 30.76 | 13.60 | |
Accounts Payable Turnover |
4.03 | 5.24 | 3.22 | 2.69 | |
Inventory Turnover |
7.12 | 8.50 | 8.64 | 7.09 | |
Average Days of Payables |
131.08 | 85.14 | 167.11 | 224.78 | |
Days of Inventory on Hand |
70.02 | 47.61 | 43.06 | 39.36 | |
Tax Rate |
0.05 | 0.04 | (0.65) | (0.13) | |
Research and Development Expense of Revenue |
5.97% | 6.36% | 7.02% | 7.11% | |
Selling, General and Administrative Expense of Revenue |
51.87% | 50.78% | 52.49% | 53.77% | |
Share Based Compensation of Revenue |
5.66% | 5.76% | 6.21% | 5.96% | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
2.43 | 2.34 | (21.18) | (1.85) | |
Depreciation/Fixed assets |
0.16 | 0.18 | 0.22 | 0.25 | |
Capex/Depreciation |
(4.44) | (3.97) | (2.77) | (1.95) | |
Revenue per Share |
9.77 | 10.44 | 10.38 | 11.12 | |
Operating CF per Share |
1.44 | 1.33 | 1.23 | 1.14 | |
Capex per Share |
(0.84) | (1.00) | (0.88) | (0.78) | |
Capex to Sales |
0.09 | 0.10 | 0.08 | 0.07 | |
Net Profit Margin |
6.05% | 5.47% | (0.56%) | (5.51%) |
Columns are period end dates